WHO monographs on selected medicinal plants - travolekar.ru
WHO monographs on selected medicinal plants - travolekar.ru
WHO monographs on selected medicinal plants - travolekar.ru
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
F<strong>ru</strong>ctus Tribuli<br />
Medicinal uses<br />
Uses supported by clinical data<br />
N<strong>on</strong>e.<br />
Uses described in pharmacopoeias and well established documents<br />
Orally for the treatment of cough, headache and mastitis (1).<br />
Although clinical trials have assessed the use of the c<strong>ru</strong>de d<strong>ru</strong>g for<br />
the symptomatic treatment of angina pectoris and male infertility<br />
(16–22), randomized c<strong>on</strong>trolled clinical trials are needed before the<br />
use of the c<strong>ru</strong>de d<strong>ru</strong>g can be recommended for the treatment of these<br />
c<strong>on</strong>diti<strong>on</strong>s.<br />
Uses described in traditi<strong>on</strong>al medicine<br />
Orally for the treatment of abdominal distensi<strong>on</strong>, diarrhoea, kidney<br />
st<strong>on</strong>es, nosebleeds and vitiligo (5, 23). Also used as an aphrodisiac, diuretic,<br />
galactagogue, general t<strong>on</strong>ic and uterine t<strong>on</strong>ic (5).<br />
Pharmacology<br />
Experimental pharmacology<br />
Angiotensin-c<strong>on</strong>verting enzyme inhibitory effects<br />
The renin-angiotensin-aldoster<strong>on</strong>e system, including angiotensinc<strong>on</strong>verting<br />
enzyme plays an important role in the c<strong>on</strong>trol of blood pressure<br />
and fluid volume (24, 25). An aqueous extract of the f<strong>ru</strong>it (1 g f<strong>ru</strong>it in<br />
10 ml water) inhibited the activity of angiotensin-c<strong>on</strong>verting enzyme in<br />
vitro at a c<strong>on</strong>centrati<strong>on</strong> of 0.33 mg/ml (24). The mechanism of acti<strong>on</strong> of<br />
the aqueous extract (500 mg f<strong>ru</strong>it in water 2:1 w/v) was investigated in<br />
2K1C hypertensive rats by measurement of circulatory and local angiotensin<br />
c<strong>on</strong>verting enzyme activity in aorta, heart, kidney and lung. Hypertensi<strong>on</strong><br />
was induced using a silver clip <strong>on</strong> the renal artery inserted by<br />
surgery. The animals were treated with a single oral daily dose of 10 mg/<br />
kg body weight (bw) of a lyophilized aqueous extract of the f<strong>ru</strong>it for<br />
4 weeks. The systolic blood pressure was increased in 2K1C rats as compared<br />
with c<strong>on</strong>trol rats. The systolic blood pressure of rats treated with<br />
the c<strong>ru</strong>de d<strong>ru</strong>g extract was significantly decreased compared to hypertensive<br />
rats (p < 0.05). The angiotensin-c<strong>on</strong>verting enzyme activity in all tissues<br />
of 2K1C rats including aorta, heart, kidney and lung as well as in the<br />
se<strong>ru</strong>m was significantly increased compared to that of normal rats. The<br />
angiotensin-c<strong>on</strong>verting enzyme activity in all tissues of hypertensive rats<br />
treated with the f<strong>ru</strong>it extract was significantly lower than that of c<strong>on</strong>trol<br />
hypertensive rats (26).<br />
327